Biopharmaceuticals / S.N. Jogdand.

Biopharmaceuticals are complex macromolecules created through the genetic manipulation of living organisms using gene cloning, recombinant DNA(gene splicing), or fusion technologies. Although small molecule drugs remain the standard treatment for disease, new strategies based on the engineering of p...

Full description

Saved in:
Bibliographic Details
Main Author: Jogdand, S. N.
Format: eBook
Language:English
Published: Mumbai : Himalaya Pub. House, 2006.
Edition:1st ed.
Subjects:
Online Access:Click for online access

MARC

LEADER 00000cam a2200000 a 4500
001 ocn681543069
003 OCoLC
005 20241006213017.0
006 m o d
007 cr cnu---unuuu
008 101116s2006 ii a ob 000 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d OCLCQ  |d E7B  |d OCLCQ  |d OCLCF  |d NLGGC  |d YDXCP  |d MERUC  |d EBLCP  |d AU@  |d OCLCQ  |d AZK  |d LOA  |d COCUF  |d MOR  |d PIFAG  |d ZCU  |d OCLCQ  |d U3W  |d STF  |d WRM  |d ICG  |d NRAMU  |d VT2  |d OCLCQ  |d WYU  |d DKC  |d OCLCQ  |d UKCRE  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCL  |d OCLCQ 
019 |a 680627109  |a 700692367  |a 764545097  |a 842269773  |a 904228028  |a 961496235  |a 962566267  |a 966261412  |a 988411024  |a 992100476  |a 1037939600  |a 1038643099  |a 1045523732  |a 1057998552  |a 1081205253  |a 1153563278 
020 |a 9781441661395  |q (electronic bk.) 
020 |a 1441661395  |q (electronic bk.) 
020 |a 9789350435298 
020 |a 9350435292 
020 |a 8183186203  |q (electronic bk.) 
020 |a 9788183186209  |q (electronic bk.) 
020 |z 9788183186209 
035 |a (OCoLC)681543069  |z (OCoLC)680627109  |z (OCoLC)700692367  |z (OCoLC)764545097  |z (OCoLC)842269773  |z (OCoLC)904228028  |z (OCoLC)961496235  |z (OCoLC)962566267  |z (OCoLC)966261412  |z (OCoLC)988411024  |z (OCoLC)992100476  |z (OCoLC)1037939600  |z (OCoLC)1038643099  |z (OCoLC)1045523732  |z (OCoLC)1057998552  |z (OCoLC)1081205253  |z (OCoLC)1153563278 
050 4 |a RM301.4  |b .J64 2006eb 
072 7 |a MED  |x 071000  |2 bisacsh 
049 |a HCDD 
100 1 |a Jogdand, S. N. 
245 1 0 |a Biopharmaceuticals /  |c S.N. Jogdand. 
250 |a 1st ed. 
260 |a Mumbai :  |b Himalaya Pub. House,  |c 2006. 
300 |a 1 online resource (277 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file  |2 rda 
504 |a Includes bibliographical references. 
588 0 |a Print version record. 
505 0 |a COVER; CONTENTS; INTRODUCTION; MARKET FOR BIOPHARMACEUTICALS; BIOPHARMACEUTICAL INDUSTRY; BIOPHARMACEUTICAL SECTOR IN INDIA; DRUG DISCOVERY AND DRUG DESIGNING; PHARMACOKINETICS; CLINICAL TRIALS; REGULATORY; THERAPEUTIC PROTEINS; BLOOD PRODUCTS; MONOCLONAL ANTIBODIES; HORMONE THERAPY; VACCINE PRODUCTION-NEW DEVELOPMENTS; TRANSGENIC PRODUCTION OF BIOPHARMACEUTICALS; HUMAN GENE THERAPY; ANTISENSE TECHNOLOGY (DNA MEDICINES). 
520 |a Biopharmaceuticals are complex macromolecules created through the genetic manipulation of living organisms using gene cloning, recombinant DNA(gene splicing), or fusion technologies. Although small molecule drugs remain the standard treatment for disease, new strategies based on the engineering of proteins, genes and cell as therapeutic agents will revolutionize medicine in the coming decades. More than 20 percent of new medicines launched in 2003 were produced using biotechnology, nearly 80 percent of those under development either use use of biotechnology or are derived from it. The biopharm. 
650 0 |a Biopharmaceutics. 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a Biopharmaceutics  |2 fast 
776 0 8 |i Print version:  |a Jogdand, S.N.  |t Biopharmaceuticals.  |b 1st ed.  |d Mumbai : Himalaya Publishing House, 2006  |z 9788183186209 
856 4 0 |u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=588365  |y Click for online access 
903 |a EBC-AC 
994 |a 92  |b HCD